Sanofi (SNY)
NASDAQ
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Return on Assets (%) | 4.55 | 8.231 | 4.077 | 2.504 | 10.825 | 5.304 | 6.779 | 4.266 |
Return on Equity (%) | 8.124 | 14.515 | 7.343 | 4.75 | 20.095 | 9.409 | 11.612 | 7.224 |
Return on Invested Capital (%) | 11.706 | 17.795 | 13.939 | 11.531 | 10.225 | 10.426 | 12.823 | 11.297 |
Operating Margin (%) | 18.588 | 35.142 | 14.172 | 9.11 | 39.702 | 21.755 | 25.311 | 19.362 |
Net Profit Margin (%) | 12.891 | 23.996 | 12.495 | 7.767 | 34.111 | 16.48 | 19.469 | 12.538 |
Book Value Per Share | 5.076 | 3.903 | -5.683 | -1.582 | 0.434 | -0.342 | 2.871 | 0.498 |
Earnings Per Share | 3.645 | 6.711 | 3.452 | 2.238 | 9.765 | 4.925 | 6.639 | 4.269 |
Cash Per Share | 7.951 | 8.226 | 5.552 | 7.518 | 11.053 | 7.992 | 10.101 | 6.886 |
Working Capital Per Share | 7.936 | 8.685 | 5.774 | 6.564 | 11.522 | 7.336 | 7.98 | 5.108 |
Operating Profit Per Share | 21.556 | 21.094 | 21.495 | 22.921 | 21.831 | 22.904 | 27.638 | 27.295 |
EBIT Per Share | 4.915 | 9.469 | 3.519 | 2.251 | 10.944 | 6.171 | 8.266 | 5.655 |
EBITDA Per Share | 4.915 | 9.469 | 3.519 | 2.251 | 10.944 | 6.171 | 8.266 | 5.655 |
Free Cash Flow Per Share | 5.928 | 8.814 | 5.349 | 3.869 | 12.029 | 7.403 | 9.027 | 7.482 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 1.29B | 1.25B | 1.25B | 1.25B | 1.26B | 1.26B | 1.26B | 1.26B |
Year End December 30 2023 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Shares Outstanding | 1.27B | 1.25B | 1.25B | 1.26B | 1.25B | 1.25B | 1.27B | 1.25B |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | 22.24 | 25.67 | N/A | 28.034 | 15.291 | N/A | 28.04 |
Net Profit Margin (%) | N/A | 16.632 | 19.517 | N/A | 21.105 | 10.828 | N/A | 20.948 |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 122.13B |
Price to Earnings Ratio | 43.04 |
Price to Sales Ratio | 5.4 |
Price to Cash Ratio | 26.68 |
Price to Book Ratio | 3.13 |
Dividend Yield | 778.79% |
Shares Outstanding | 2.53B |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.